William Thomas, MD
Interventional Cardiology · Tucson, AZNPI 1891773024
Payments from drug & device makers
Across 442 payments — averaging $159.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$37K
- Edwards Lifesciences$19K
- Lilly USA, LLC$6K
- Abbott$2K
- Boston Scientific$2K
- Novartis$700
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 39 | $36,945 |
| Edwards Lifesciences | 98 | $19,268 |
| Lilly USA, LLC | 7 | $6,219 |
| Abbott | 30 | $2,451 |
| Boston Scientific | 34 | $1,796 |
| Novartis | 72 | $700 |
| Medtronic(2 entities) | 7 | $436 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $341 |
| Johnson & Johnson(2 entities) | 19 | $332 |
| Astellas Pharma US Inc | 9 | $265 |
| Amgen | 17 | $242 |
| Pfizer | 13 | $196 |
| Cardiva Medical, Inc. | 23 | $190 |
| Cardiac Dimensions, Inc. | 1 | $115 |
| Sanofi-aventis U.S. LLC | 7 | $113 |
| Biotronik Inc. | 5 | $107 |
| Philips North America LLC | 1 | $94 |
| Bard Peripheral Vascular, Inc. | 1 | $93 |
| AstraZeneca | 6 | $86 |
| Esperion Therapeutics, Inc. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 4 | $63 |
| Chiesi USA, Inc. | 2 | $51 |
| Amarin Pharma, Inc. | 4 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Kestra Medical Technology Services, Inc. | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Caris MPI, Inc. | 1 | $33 |
| Lundbeck LLC | 2 | $33 |
| Abiomed | 1 | $30 |
| Merck | 2 | $30 |
| Impulse Dynamics (USA) Inc. | 1 | $24 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
How this compares
$70,544 in reported general payments places this provider in the 80th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Tucson
- Thomas WaggonerTucson$4.1M
- Ajay TuliTucson$705K
- Kapildeo LotunTucson$488K
- Neil GheewalaTucson$319K
- Ryan TsudaTucson$245K
- Michel CorbanTucson$106K
- Dexter de LeonTucson$90K
- Brenda PeartTucson$66K
- Ranjith ShettyTucson$50K
- Santiago RamirezTucson$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.